127 related articles for article (PubMed ID: 38301909)
1. NR4A1 depletion inhibits colorectal cancer progression by promoting necroptosis via the RIG-I-like receptor pathway.
Zhu J; Li J; Yang K; Chen Y; Wang J; He Y; Shen K; Wang K; Shi T; Chen W
Cancer Lett; 2024 Mar; 585():216693. PubMed ID: 38301909
[TBL] [Abstract][Full Text] [Related]
2. TRAF6 regulates the abundance of RIPK1 and inhibits the RIPK1/RIPK3/MLKL necroptosis signaling pathway and affects the progression of colorectal cancer.
Lin P; Lin C; He R; Chen H; Teng Z; Yao H; Liu S; Hoffman RM; Ye J; Zhu G
Cell Death Dis; 2023 Jan; 14(1):6. PubMed ID: 36604411
[TBL] [Abstract][Full Text] [Related]
3. Key necroptotic proteins are required for Smac mimetic-mediated sensitization of cholangiocarcinoma cells to TNF-α and chemotherapeutic gemcitabine-induced necroptosis.
Akara-Amornthum P; Lomphithak T; Choksi S; Tohtong R; Jitkaew S
PLoS One; 2020; 15(1):e0227454. PubMed ID: 31914150
[TBL] [Abstract][Full Text] [Related]
4. CAMK2/CaMKII activates MLKL in short-term starvation to facilitate autophagic flux.
Zhan Q; Jeon J; Li Y; Huang Y; Xiong J; Wang Q; Xu TL; Li Y; Ji FH; Du G; Zhu MX
Autophagy; 2022 Apr; 18(4):726-744. PubMed ID: 34282994
[TBL] [Abstract][Full Text] [Related]
5. ABIN-1 is a key regulator in RIPK1-dependent apoptosis (RDA) and necroptosis, and ABIN-1 deficiency potentiates necroptosis-based cancer therapy in colorectal cancer.
Cai J; Hu D; Sakya J; Sun T; Wang D; Wang L; Mao X; Su Z
Cell Death Dis; 2021 Feb; 12(2):140. PubMed ID: 33542218
[TBL] [Abstract][Full Text] [Related]
6. FKBP12 mediates necroptosis by initiating RIPK1-RIPK3-MLKL signal transduction in response to TNF receptor 1 ligation.
Wang Z; Feng J; Yu J; Chen G
J Cell Sci; 2019 May; 132(10):. PubMed ID: 31028177
[TBL] [Abstract][Full Text] [Related]
7. OSW-1 triggers necroptosis in colorectal cancer cells through the RIPK1/RIPK3/MLKL signaling pathway facilitated by the RIPK1-p62/SQSTM1 complex.
Wang N; Li CY; Yao TF; Kang XD; Guo HS
World J Gastroenterol; 2024 Apr; 30(15):2155-2174. PubMed ID: 38681991
[TBL] [Abstract][Full Text] [Related]
8. c-Jun N-terminal kinases differentially regulate TNF- and TLRs-mediated necroptosis through their kinase-dependent and -independent activities.
Cao M; Chen F; Xie N; Cao MY; Chen P; Lou Q; Zhao Y; He C; Zhang S; Song X; Sun Y; Zhu W; Mou L; Luan S; Gao H
Cell Death Dis; 2018 Nov; 9(12):1140. PubMed ID: 30442927
[TBL] [Abstract][Full Text] [Related]
9. Depletion of RIPK3 or MLKL blocks TNF-driven necroptosis and switches towards a delayed RIPK1 kinase-dependent apoptosis.
Remijsen Q; Goossens V; Grootjans S; Van den Haute C; Vanlangenakker N; Dondelinger Y; Roelandt R; Bruggeman I; Goncalves A; Bertrand MJ; Baekelandt V; Takahashi N; Berghe TV; Vandenabeele P
Cell Death Dis; 2014 Jan; 5(1):e1004. PubMed ID: 24434512
[TBL] [Abstract][Full Text] [Related]
10. Receptor-interacting protein kinase 1 is a key mediator in TLR3 ligand and Smac mimetic-induced cell death and suppresses TLR3 ligand-promoted invasion in cholangiocarcinoma.
Lomphithak T; Choksi S; Mutirangura A; Tohtong R; Tencomnao T; Usubuchi H; Unno M; Sasano H; Jitkaew S
Cell Commun Signal; 2020 Oct; 18(1):161. PubMed ID: 33036630
[TBL] [Abstract][Full Text] [Related]
11. Interferon-γ induces the cell surface exposure of phosphatidylserine by activating the protein MLKL in the absence of caspase-8 activity.
Chen J; Kuroki S; Someda M; Yonehara S
J Biol Chem; 2019 Aug; 294(32):11994-12006. PubMed ID: 31217278
[TBL] [Abstract][Full Text] [Related]
12. Celastrol inhibits necroptosis by attenuating the RIPK1/RIPK3/MLKL pathway and confers protection against acute pancreatitis in mice.
Liang QQ; Shi ZJ; Yuan T; Chen SY; Li YP; Zhang HR; You YP; Xu R; Xu LH; Hu B; Ouyang DY; Zha QB; He XH
Int Immunopharmacol; 2023 Apr; 117():109974. PubMed ID: 37012867
[TBL] [Abstract][Full Text] [Related]
13. Dimethyl fumarate inhibits necroptosis and alleviates systemic inflammatory response syndrome by blocking the RIPK1-RIPK3-MLKL axis.
Shi FL; Yuan LS; Wong TS; Li Q; Li YP; Xu R; You YP; Yuan T; Zhang HR; Shi ZJ; Zha QB; Hu B; He XH; Ouyang DY
Pharmacol Res; 2023 Mar; 189():106697. PubMed ID: 36796462
[TBL] [Abstract][Full Text] [Related]
14. A novel lncRNA NR4A1AS up-regulates orphan nuclear receptor NR4A1 expression by blocking UPF1-mediated mRNA destabilization in colorectal cancer.
Xie X; Lin J; Liu J; Huang M; Zhong Y; Liang B; Song X; Gu S; Chang X; Huang D; Tang A
Clin Sci (Lond); 2019 Jul; 133(13):1457-1473. PubMed ID: 31253658
[TBL] [Abstract][Full Text] [Related]
15. Opposite Effects of Apoptotic and Necroptotic Cellular Pathways on Rotavirus Replication.
Soliman M; Seo JY; Baek YB; Park JG; Kang MI; Cho KO; Park SI
J Virol; 2022 Jan; 96(1):e0122221. PubMed ID: 34668777
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Neural Stem Cell Necroptosis Mediated by RIPK1/MLKL Promotes Functional Recovery After SCI.
Tong K; Li S; Chen G; Ma C; Liu X; Liu S; Chen N
Mol Neurobiol; 2023 Apr; 60(4):2135-2149. PubMed ID: 36602703
[TBL] [Abstract][Full Text] [Related]
17. Molecular Insights into the Mechanism of Necroptosis: The Necrosome As a Potential Therapeutic Target.
Chen J; Kos R; Garssen J; Redegeld F
Cells; 2019 Nov; 8(12):. PubMed ID: 31766571
[TBL] [Abstract][Full Text] [Related]
18. The neurotoxicant PCB-95 by increasing the neuronal transcriptional repressor REST down-regulates caspase-8 and increases Ripk1, Ripk3 and MLKL expression determining necroptotic neuronal death.
Guida N; Laudati G; Serani A; Mascolo L; Molinaro P; Montuori P; Di Renzo G; Canzoniero LMT; Formisano L
Biochem Pharmacol; 2017 Oct; 142():229-241. PubMed ID: 28676433
[TBL] [Abstract][Full Text] [Related]
19. TNF-α-dependent neuronal necroptosis regulated in Alzheimer's disease by coordination of RIPK1-p62 complex with autophagic UVRAG.
Xu C; Wu J; Wu Y; Ren Z; Yao Y; Chen G; Fang EF; Noh JH; Liu YU; Wei L; Chen X; Sima J
Theranostics; 2021; 11(19):9452-9469. PubMed ID: 34646380
[No Abstract] [Full Text] [Related]
20. A natural chalcone cardamonin inhibits necroptosis and ameliorates dextran sulfate sodium (DSS)-induced colitis by targeting RIPK1/3 kinases.
Shen X; Chen H; Wen T; Liu L; Yang Y; Xie F; Wang L
Eur J Pharmacol; 2023 Sep; 954():175840. PubMed ID: 37302524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
